Trial intelligence / Profile preview

PRP Injections After ACL Reconstruction

NCT06442319Recruiting

Sponsor
Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz
Start
Jun 2024
Primary completion
Apr 2028
Modality
Adipose-derived MSCs, Bone Marrow MSCs
Countries
1
01

Overview

Randomised trial of platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz. Primary endpoints: Knee Pain Score at 12 months and Cartilage Volume at 12 months. Started Jun 2024; status: recruiting.

02

Drugs

platelet-rich plasma
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06442319.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06442319.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call